HEALTH

GTC Nutrition, Ganeden Biotech to develop prebiotic, probiotic ingredients

BY Michael Johnsen

GOLDEN, Colo. GTC Nutrition, a business unit of Corn Products International, on Thursday announced that it has formed a strategic alliance with Ganeden Biotech, to work together in the development of prebiotic and probiotic ingredients.

“Partnering with an industry leader such as GTC Nutrition will enable us to broaden the applications of GanedenBC30 into more functional foods and beverages, nutraceuticals and animal health applications,” stated Andrew Lefkowitz, Ganeden’s president and chief executive officer.

Probiotics are “good for you” bacteria that are similar to the good bacteria found naturally in the body’s digestive tract that can support healthy digestive and immune systems. Prebiotics serve as food for probiotics. A prebiotic is a non-digestible carbohydrate that works in the intestines to nourish and stimulate the growth of the good bacteria, which, in turn. helps to maintain a healthy digestive environment. Prebiotics and probiotics work synergistically to maintain healthy digestion and support immune system strength.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

ASCP launches chronic constipation education initiative

BY Michael Johnsen

ALEXANDRIA, Va. The American Society of Consultant Pharmacists on Thursday launched a comprehensive continuing medical education initiative for physicians, nurses, pharmacists and other health-care providers about chronic constipation.

Known as E-IMPACCT, Elderly IMProvements and Advances in Chronic Constipation Treatment, the program presents educational activities on evaluating and managing CC, and offers a range of tools to help clinicians in everyday practice.

 “Because of the cascade of complex health issues that can be triggered by chronic constipation, clinicians have expressed their need for targeted education about CC,” stated ASCP executive director and chief executive officer John Feather. “Clinicians need to identify, recognize and differentiate CC and have a clear understanding of the pros and cons of each of the treatments and medications, the side effects and administration and efficacy data.”

“For all clinicians, the management strategies for treating chronic constipation in the elderly should include a combination of patient and caregiver education and communication, dietary modifications, and treatment options,” commented ASCP director of professional and educational affairs Trish D’Antonio Mazzuca. “Educational outcomes from E-IMPACCT will measure changes in clinician knowledge and behavior and improvements in patient care.”

E-IMPACCT provides outcomes-based knowledge through an ongoing, thorough awareness campaign with educational components that will roll out over a 12-month period. Through this initiative, participants are presented with new information and certified continuing education activities, patient cases and guidelines designed to help clinicians better manage CC and improve outcomes in today’s seniors.

Chronic constipation is the most common digestive complaint in the general population. In seniors, roughly 26 percent of men and 34 percent of women complain of constipation. Americans spend approximately $800 million per year on over-the-counter laxatives, the society reported.

The ASCP E-IMPACCT initiative is supported by an educational grant from Sucampo Pharmaceuticals and Takeda Pharmaceuticals North America.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

GlaxoSmithKline wins recommendation to sell Alli in Europe

BY Michael Johnsen

LONDON GlaxoSmithKline won a recommendation from European regulators Thursday that it be allowed to sell its weight loss drug Alli over-the-counter in Europe.

The European Medicines Agency said it had recommended the switch from prescription-only to nonprescription for a 60-milligram dose of alli, the same dose approved for sale OTC in the United States. The European Commission now needs to rubber-stamp the recommendation.

The European Medicines Agency said it had recommended the switch from prescription-only to nonprescription for a 60-milligram dose of alli, the same dose approved for sale OTC in the United States. The European Commission now needs to rubber-stamp the recommendation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?